Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Arsagera reported for 6 months of 2023 by RAS

8/1/23 ARSA

X5 Retail Group buys Victoria chain

8/1/23 -

Tinkoff Auto will develop a fintech platform for the electric car Atom

8/1/23 T

Toyota reported for 3 months of fiscal year 2024

8/1/23 7203

BioMarin Pharmaceutical reported for 6 months in 2023

8/1/23 BMRN

LSR will build a large neighborhood on the site of the Danone dairy plant

8/1/23 LSRG

Seligdar reports for 6 months of 2023 by RAS

8/1/23 SELG

Sistema JSFC reported for 6 months of 2023 by RAS

8/1/23 AFKS

Rusolovo reported for 6 months of 2023 by RAS

7/31/23 ROLO

Alrosa invested in a joint venture in Zimbabwe $15 mln

7/31/23 ALRS